Lung cancer (non-small-cell) - pemetrexed
Pemetrexed for the treatment of non-small-cell lung cancer
Summary
Pemetrexed has now been recommended for the first-line treatment of non-small-cell lung cancer (see www.nice.org.uk/TA181). Technology appraisal guidance 124 applies to patients who have had prior chemotherapy. Pemetrexed is not recommended for the treatment of locally advanced or metastatic non ...
Guidance documents
Implementing this guidance
Other information
We will consult on our review plans for this guidance in January 2010
About this guidance
Technology appraisals TA124
Issued: August 2007
How this guidance was produced